Intravenous Market - Forecast 2021-2026
Intravenous Market Overview
Intravenous Market size is estimated to reach $33.6 billion by 2026, growing at a CAGR of 6.4% during the forecast period 2021-2026. Intravenous generally refers to giving medicines through a needle inserted into a vein to enter the bloodstream right away. It is generally used for rehydration and also to provide nutrition for people who cannot consume food by mouth. It also avoids the first-pass drug effect and results in the direct entry of drugs into the process of systemic circulation. Intravenous solutions and devices have become a vital part of the healthcare system of various nations, enabling doctors to help hydrate their patients, administer drugs, and replace lost blood volume. Rise in the prevalence of malnutrition, growing demand for intravenous catheters during surgical procedures for the transfer of nutrients such as parenteral lipid emulsion and single dose amino acid solution, and rise in the adoption of peripheral parenteral nutrition method in developed nations are the factors that are set to drive the growth of the Intravenous Market for the period 2021-2026.
Report Coverage
The report: “Intravenous Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Intravenous Market.
By Product Type: Implantable Port, Intravenous Catheter, Infusion Pumps, Hypodermic Needles, and Others.
By Nutrient: Carbohydrates, Vitamins and Minerals, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, and Others.
By Application: Medication Administration, Volume Expanders, Nutrition and Buffer Solution, and Others.
By End User: Hospitals, Clinics, Ambulatory Surgical Centers, and Others.
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World (Middle East and Africa).
Geographically, North America Intravenous Market accounted for the highest revenue share in 2020 and it is poised to dominate over the period 2021-2026 owing to the growing adoption of peripheral parenteral nutrition method in developed nations
The rise in the adoption of catheters for the transfer of nutrients such as parenteral lipid emulsion and single dose amino acid solution is driving the Intravenous Catheter segment. However, the stringent government regulations for intravenous fluids is one of the major factors that is said to reduce the growth of the Intravenous Market.
Detailed analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Intravenous Market report.
Intravenous Market Size, By Product Type, 2020-2026 (USD Million)
For more details on this report - Request for Sample
Intravenous Market Segment Analysis-By Product Type
The Intravenous Market based on the Product Type can be further segmented into Implantable Port, Intravenous Catheter, Infusion Pumps, Hypodermic Needles, and Others. The Intravenous Catheter segment held the largest share in 2020 and is also estimated to be the fastest growing segment with a CAGR of 7.3% over the period 2021-2026. This growth is owing to the factors such as growing demand for intravenous catheters during surgical procedures for intravenous therapies in developed nations and increasing demand for advanced intravenous catheters. The rise in the adoption of these catheters for the transfer of nutrients such as parenteral lipid emulsion and single dose amino acid solution is driving the growth of the Intravenous Market. The Implantable Port segment held the second-largest share in 2020 owing to the factors such as the reduced risk of infection, low-maintenance, and less interference with patients' daily activities.
Intravenous Market Segment Analysis-By Nutrient
The Intravenous Market based on the Nutrient can be further segmented into Carbohydrates, Vitamins and Minerals, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, and Others. The Single Dose Amino Acid Solution segment held the largest share in 2020 owing to the factors such as growing prevalence of protein deficiency diseases and hepatic diseases and increase in the consumption of amino acid injections. The rise in the approvals of enhanced amino acid solutions with less adverse effects is driving the growth of the Intravenous Market. The Vitamins and Minerals is estimated to be the fastest growing segment with a CAGR of 7.5% over the period 2021-2026. This growth is owing to the factors such as rise in the number of surgeries and the growing adoption of post-operative nutritional management for the treatment of diseases, such as anemia, pellagra, and chronic mental conditions.
North America held the largest share with 28% of the overall market in 2020. The growth in this segment is owing to the factors such as rise in the prevalence of malnutrition and the growing utilization of intravenous therapy devices. The rise in the adoption of peripheral parenteral nutrition methods in developed nations is driving the growth of the Intravenous Market. Asia-Pacific is estimated to be the fastest growing segment over the period 2021-2026. The growth in this segment is owing to the factors such as growing demand for intravenous catheters during surgical procedures for the transfer of nutrients such as parenteral lipid emulsion and single dose amino acid solution and rise in the number of chronic diseases.
Intravenous Market Drivers
Increase in the Demand for Intravenous Catheters.
Intravenous Catheters are playing a dominant role in therapeutic purposes such as the administration of medications and blood sampling. Intravenous Catheters are the most commonly used intravenous device in hospitalized patients as it promotes safety by reducing the risk of blood exposure, which is propelling the growth of the Intravenous Market.
Rise in the Adoption of Peripheral Parenteral Nutrition.
There is an increase in the adoption of peripheral parenteral nutrition methods in developed nations as it provides various nutrients such as parenteral lipid emulsion and single dose amino acid solution and medications intravenously. The Peripheral parenteral nutrition method is also increasingly being recommended for patients who are malnourished and are not candidates for enteral nutrition, which is one of the major factors driving the growth of the Intravenous Market.
Intravenous Market Challenges
Stringent Government Regulations for Intravenous Fluids.
Intravenous solutions and devices have become a vital part of the healthcare system of various nations, enabling doctors to help hydrate their patients, administer drugs, and replace lost blood volume. However, Intravenous fluids are regulated as pharmaceutical products, which is one of the major factors that is estimated to reduce the growth of the Intravenous Market.
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Intravenous Market. Key companies of this market are B. Braun Melsungen AG, Becton, Dickinson And Company, Insulet Corporation, Medtronic Inc, Pfizer Inc, Teleflex Medical Inc, Terumo Medical Corporation, Smith Nephew Plc, Otsuka Pharmaceutical Co Ltd, and Fresenius SE & Co KGaA among others.
Acquisitions/Product Launches:
In November 2020, Otsuka Pharmaceutical has launched ENEFLUID Injection, a peripheral parenteral nutrition solution that combines fat and water-soluble vitamins in addition to glucose, electrolytes, and amino acid solution in a dual-chamber bag.
In October 2020, Pfizer has acquired Arixa Pharmaceuticals for its lead compound ARX-1796, an intravenous combination with ceftazidime for the treatment of several indications. It helps the patients to leave the hospital earlier and also avoids the need for hospital admission.
In April 2019, B. Braun Melsungen AG has launched Heparin Sodium Injection, USP, which is the first Heparin prefilled syringe with attached safety needle for intravenous use in the United States. This product is launched to develop products designed to increase patient safety and improve dosage accuracy and workflows.
Intravenous Market size is estimated to reach $33.6 billion by 2026, growing at a CAGR of 6.4% during the forecast period 2021-2026. Intravenous generally refers to giving medicines through a needle inserted into a vein to enter the bloodstream right away. It is generally used for rehydration and also to provide nutrition for people who cannot consume food by mouth. It also avoids the first-pass drug effect and results in the direct entry of drugs into the process of systemic circulation. Intravenous solutions and devices have become a vital part of the healthcare system of various nations, enabling doctors to help hydrate their patients, administer drugs, and replace lost blood volume. Rise in the prevalence of malnutrition, growing demand for intravenous catheters during surgical procedures for the transfer of nutrients such as parenteral lipid emulsion and single dose amino acid solution, and rise in the adoption of peripheral parenteral nutrition method in developed nations are the factors that are set to drive the growth of the Intravenous Market for the period 2021-2026.
Report Coverage
The report: “Intravenous Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Intravenous Market.
By Product Type: Implantable Port, Intravenous Catheter, Infusion Pumps, Hypodermic Needles, and Others.
By Nutrient: Carbohydrates, Vitamins and Minerals, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, and Others.
By Application: Medication Administration, Volume Expanders, Nutrition and Buffer Solution, and Others.
By End User: Hospitals, Clinics, Ambulatory Surgical Centers, and Others.
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World (Middle East and Africa).
Key Takeaways
Geographically, North America Intravenous Market accounted for the highest revenue share in 2020 and it is poised to dominate over the period 2021-2026 owing to the growing adoption of peripheral parenteral nutrition method in developed nations
The rise in the adoption of catheters for the transfer of nutrients such as parenteral lipid emulsion and single dose amino acid solution is driving the Intravenous Catheter segment. However, the stringent government regulations for intravenous fluids is one of the major factors that is said to reduce the growth of the Intravenous Market.
Detailed analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Intravenous Market report.
Intravenous Market Size, By Product Type, 2020-2026 (USD Million)
For more details on this report - Request for Sample
Intravenous Market Segment Analysis-By Product Type
The Intravenous Market based on the Product Type can be further segmented into Implantable Port, Intravenous Catheter, Infusion Pumps, Hypodermic Needles, and Others. The Intravenous Catheter segment held the largest share in 2020 and is also estimated to be the fastest growing segment with a CAGR of 7.3% over the period 2021-2026. This growth is owing to the factors such as growing demand for intravenous catheters during surgical procedures for intravenous therapies in developed nations and increasing demand for advanced intravenous catheters. The rise in the adoption of these catheters for the transfer of nutrients such as parenteral lipid emulsion and single dose amino acid solution is driving the growth of the Intravenous Market. The Implantable Port segment held the second-largest share in 2020 owing to the factors such as the reduced risk of infection, low-maintenance, and less interference with patients' daily activities.
Intravenous Market Segment Analysis-By Nutrient
The Intravenous Market based on the Nutrient can be further segmented into Carbohydrates, Vitamins and Minerals, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, and Others. The Single Dose Amino Acid Solution segment held the largest share in 2020 owing to the factors such as growing prevalence of protein deficiency diseases and hepatic diseases and increase in the consumption of amino acid injections. The rise in the approvals of enhanced amino acid solutions with less adverse effects is driving the growth of the Intravenous Market. The Vitamins and Minerals is estimated to be the fastest growing segment with a CAGR of 7.5% over the period 2021-2026. This growth is owing to the factors such as rise in the number of surgeries and the growing adoption of post-operative nutritional management for the treatment of diseases, such as anemia, pellagra, and chronic mental conditions.
Intravenous Market Segment Analysis-By Geography
North America held the largest share with 28% of the overall market in 2020. The growth in this segment is owing to the factors such as rise in the prevalence of malnutrition and the growing utilization of intravenous therapy devices. The rise in the adoption of peripheral parenteral nutrition methods in developed nations is driving the growth of the Intravenous Market. Asia-Pacific is estimated to be the fastest growing segment over the period 2021-2026. The growth in this segment is owing to the factors such as growing demand for intravenous catheters during surgical procedures for the transfer of nutrients such as parenteral lipid emulsion and single dose amino acid solution and rise in the number of chronic diseases.
Intravenous Market Drivers
Increase in the Demand for Intravenous Catheters.
Intravenous Catheters are playing a dominant role in therapeutic purposes such as the administration of medications and blood sampling. Intravenous Catheters are the most commonly used intravenous device in hospitalized patients as it promotes safety by reducing the risk of blood exposure, which is propelling the growth of the Intravenous Market.
Rise in the Adoption of Peripheral Parenteral Nutrition.
There is an increase in the adoption of peripheral parenteral nutrition methods in developed nations as it provides various nutrients such as parenteral lipid emulsion and single dose amino acid solution and medications intravenously. The Peripheral parenteral nutrition method is also increasingly being recommended for patients who are malnourished and are not candidates for enteral nutrition, which is one of the major factors driving the growth of the Intravenous Market.
Intravenous Market Challenges
Stringent Government Regulations for Intravenous Fluids.
Intravenous solutions and devices have become a vital part of the healthcare system of various nations, enabling doctors to help hydrate their patients, administer drugs, and replace lost blood volume. However, Intravenous fluids are regulated as pharmaceutical products, which is one of the major factors that is estimated to reduce the growth of the Intravenous Market.
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Intravenous Market. Key companies of this market are B. Braun Melsungen AG, Becton, Dickinson And Company, Insulet Corporation, Medtronic Inc, Pfizer Inc, Teleflex Medical Inc, Terumo Medical Corporation, Smith Nephew Plc, Otsuka Pharmaceutical Co Ltd, and Fresenius SE & Co KGaA among others.
Acquisitions/Product Launches:
In November 2020, Otsuka Pharmaceutical has launched ENEFLUID Injection, a peripheral parenteral nutrition solution that combines fat and water-soluble vitamins in addition to glucose, electrolytes, and amino acid solution in a dual-chamber bag.
In October 2020, Pfizer has acquired Arixa Pharmaceuticals for its lead compound ARX-1796, an intravenous combination with ceftazidime for the treatment of several indications. It helps the patients to leave the hospital earlier and also avoids the need for hospital admission.
In April 2019, B. Braun Melsungen AG has launched Heparin Sodium Injection, USP, which is the first Heparin prefilled syringe with attached safety needle for intravenous use in the United States. This product is launched to develop products designed to increase patient safety and improve dosage accuracy and workflows.
- We also publish more than 100 reports every month in “Lifesciences and Healthcare”, Go through the Domain if there are any other areas for which you would like to get a market research study.
Comments
Post a Comment